Drägerwerk AG & Co. KGaA (FRA:DRW3)
| Market Cap | 1.22B |
| Revenue (ttm) | 3.42B |
| Net Income (ttm) | 120.88M |
| Shares Out | n/a |
| EPS (ttm) | n/a |
| PE Ratio | 10.06 |
| Forward PE | 9.75 |
| Dividend | 2.03 (2.91%) |
| Ex-Dividend Date | May 12, 2025 |
| Volume | n/a |
| Average Volume | 59 |
| Open | 70.00 |
| Previous Close | 69.90 |
| Day's Range | 70.00 - 70.00 |
| 52-Week Range | 43.15 - 77.10 |
| Beta | n/a |
| RSI | 51.99 |
| Earnings Date | Mar 24, 2026 |
About Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departmen... [Read more]
Financial Performance
In 2024, Drägerwerk AG & Co. KGaA's revenue was 3.37 billion, a decrease of -0.08% compared to the previous year's 3.37 billion. Earnings were 124.41 million, an increase of 12.65%.
Financial StatementsNews
EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Miscellaneous Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final...
Drägerwerk AG & Co. KGaA 2025 Q3 - Results - Earnings Call Presentation
2025-11-02. The following slide deck was published by Drägerwerk AG & Co.
Drägerwerk AG & Co. KGaA (DGWPF) Q3 2025 Earnings Call Transcript
Drägerwerk AG & Co. KGaA (OTCPK:DGWPF) Q3 2025 Earnings Call October 29, 2025 10:00 AM EDTCompany ParticipantsStefan Dräger - Chairman of the Executive...
Draegerwerk Soars: Strong Demand & Stellar Earnings in 2025
In the bustling world of business, Drägerwerk AG & Co. KGaA shines with remarkable growth and robust earnings, marking a triumphant first nine months of 2025. Jetzt den vollständigen Artikel lesen
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong demand, noticeable net sales growth and very good earnings performance in the first nine months of 2025
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): 9 Month figures/Quarter Results Drägerwerk AG & Co. KGaA: Dräger with strong demand, noticeable net sales growth and very good earnings performance in...
Drägerwerk Q3 2025: Sales & Earnings Surge, Top Forecast Range
Drägerwerk AG & Co. KGaA has showcased impressive growth in Q3 2025, with significant boosts in sales and profitability across its divisions. Jetzt den vollständigen Artikel lesen
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2025: Significant increase in net sales and earnings – upper half of forecast range expected
EQS-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/Forecast Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2025: Significant increase in net sales and earnings – upper half of f...
Drägerwerk AG & Co. KGaA 2025 Q2 - Results - Earnings Call Presentation
Drägerwerk AG & Co. KGaA (DGWPF) Q2 2025 Earnings Call Transcript
Draegerwerk: Record Demand Surge in Early 2025 Orders!
Drägerwerk AG & Co. KGaA has marked a milestone with a surge in order intake, showcasing its robust market presence and strategic growth trajectory. The company reported its highest demand in five yea...
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong order intake in the first half of 2025 – Highest demand in five years
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Half Year Report/Half Year Results Drägerwerk AG & Co. KGaA: Dräger with strong order intake in the first half of 2025 – Highest demand in five years ...
Drägerwerk: H1 2025 Earnings Dip, Orders Surge, Forecast Steady
Drägerwerk AG & Co. KGaA navigates a challenging financial landscape, reporting a dip in EBIT yet celebrating a robust order intake surge in the first half of 2025. Jetzt den vollständigen Artikel les...
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures H1 2025: Earnings positive but below prior year – net sales stable – significant increase in order intake – forecast confirmed
EQS-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/Forecast Drägerwerk AG & Co. KGaA: Preliminary figures H1 2025: Earnings positive but below prior year – net sales stable – sign...
EQS-AFR: Drägerwerk AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: Drägerwerk AG & Co. KGaA / Preliminary announcement on the disclosure of financial statements Drägerwerk AG & Co. KGaA: Preliminary announcement of the ...
Drägerwerk AG & Co KGaA (DGWPF) Q1 2025 Earnings Call Transcript
Drägerwerk AG & Co KGaA (OTCPK:DGWPF) Q1 2025 Results Conference Call April 30, 2025 8:00 AM ET Company Participants Nikolaus Hammerschmidt - IR Tom Fischler - IR Stefan Dräger - Chief Executive Offic...
Drägerwerk AG & Co KGaA (DGWPF) Full Year 2024 Earnings Call Transcript
Drägerwerk AG & Co KGaA (OTCPK:DGWPF) Full Year 2024 Earnings Conference Call March 31, 2025 9:00 AM ET Company Participants Stefan Dräger – Chief Executive Officer Gert-Hartwig Lescow – Chief Financi...